Nr 546 week 6 Study guides, Class notes & Summaries

NR 546 Week 7 ADHD Medication Table Latest. Drug Name (include if IR, XR, ODT, LA) Indication (include approved ages) Neurotransmitter(s) Affected Target Symptoms Short-acting, intermediate-acting or long-acting. Duration of action, peak (if noted) Notable side effects /Patient education instructions Methylphenidate (D/L) (Concerta, Ritalin) Indication (include approved ages) Attention deficit hyperactivity disorder (ADHD) in children and adults (approved ages vary base...

CASE STUDY 1 HISTORY OF PRESENT ILLNESS: A 27-year-old male was brought to ED by his wife. He has been experiencing chest pain for 1 day starting at 2:00 a.m. He is triaged to the medical emergency department. Amedical history is taken. The client has no history of myocardial infarction (MI) orhypertension. The client is irritable and hypervigilant. He repeatedly asks the nurse if “you know what you are doing” and becomes increasingly guarded as the intern requests more details about his m...

NR 546 WEEK 1 Quiz TO Week 6 Quiz with Accurate answers NR 546 WEEK 1 Quiz What should the PMHNP consider when prescribing chemical restraints? --*correct answer*---allergy status -prior med hx for adverse drug reactions r/t the meds ordered in the chemical restraint -state regulations regarding chemical restrains must be reviewed How does reviewing the genetic makeup of a client help guide the PMHNP in selecting medication for clients? --*correct answer*---Genetic testing can assist b...

NR 546 Week 7 ADHD Medication Table Latest. Drug Name (include if IR, XR, ODT, LA) Indication (include approved ages) Neurotransmitter(s) Affected Target Symptoms Short-acting, intermediate-acting or long-acting. Duration of action, peak (if noted) Notable side effects /Patient education instructions Methylphenidate (D/L) (Concerta, Ritalin) Indication (include approved ages) Attention deficit hyperactivity disorder (ADHD) in children and adults (approved ages vary base...

Midterm Exam: NR546/ NR 546 (NEW Update 2024/ 2025) Psychopharmacology for the Psychiatric-Mental Health Nurse Practitioner Review |Weeks 1-4 | Questions and Verified Answers| 100% Correct- Chamberlain QUESTION Haloperidol, ziprasidone, and olanzapine Answer: increased risk of CVA, cognitive decline, and death in older adults with dementia and dementia related psychosis QUESTION aripiprazole black box warning Answer: medication with increased risk of suicide in...

NR 546 Week 6 Case Study; Addiction

NR 546 Week 6 Addiction Medication Table QUESTIONS AND CORRECT DETAILED ANSWERS WITH RATIONALES (VERIFIED ANSWERS) |ALREADY GRADED A+ Drug Name Indication Neurotransmitter(s) Affected Target Symptoms Half-life (T1/2), Metabolism (CYP 450 enzyme) Notable Side Effects (link to NT or affected brain circuit) Initial Dosing Considerations Specific lifespan considerations (age, pregnancy, breastfeeding) Buprenorphine (Subutex) Indication: • Maintenance treatment of opioid dep...

NR 546 Week 6 Addiction Medication Table QUESTIONS AND CORRECT DETAILED ANSWERS WITH RATIONALES (VERIFIED ANSWERS) |ALREADY GRADED A+

NR 546 Week 6 Addiction Medication Table QUESTIONS AND CORRECT DETAILED ANSWERS WITH RATIONALES (VERIFIED ANSWERS) |ALREADY GRADED A+

NR 546 Week 6 Addiction Medication Table QUESTIONS AND CORRECT DETAILED ANSWERS WITH RATIONALES (VERIFIED ANSWERS) |ALREADY GRADED A+